3 Secular Trends Every Canadian Investor Should Know

Benefit from these secular trends by investing in BCE Inc. (TSX:BCE)(NYSE:BCE), Brookfield Renewable Energy Partners L.P. (TSX:BEP.UN)(NYSE:BEP), and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

Identifying and understanding secular trends is an important aspect of investing because they are capable of triggering fundamental technological, demographic and economic shifts. This can make them highly disruptive, but also benefit companies offering products or services that take advantage of those distinct changes. As a result they can offer investors the opportunity for outsized returns with their ability to continue growing regardless of the fluctuations in the economic cycle.

Let’s take a closer look at three secular trends I think every investor must consider.

1. Growing demand for data in the information age

Data and its high speed transmission has become an important part of our daily lives. Not only are companies increasingly in need of the means for the timely transmission of data in order to conduct business activities but consumers are demanding greater access to information in our increasingly interconnected world.

This trend will be of considerable benefit to Canada’s three largest telcos: BCE Inc. (TSX:BCE)(NYSE:BCE), Rogers Communications Inc. (TSX:RCI.B) (NYSE:RCI) and Telus Corp. (TSX:T)(NYSE:TU). This is because they operate in an oligopolistic market with steep barriers to entry that protect their competitive advantage and shield them from the disruptive impact fast-changing communications technology.

More importantly, they will benefit from this secular tailwind because of their large national wireless and cable networks that allow them to offer the full suite of data, media and entertainment solutions for businesses and consumers.

2. A shift away from fossil fuels to renewable energy sources

As fears about global warming grow, governments are moving fast to reduce greenhouse emissions and carbon footprints. They are doing this by way of steeper regulations, higher renewable energy targets, increased carbon levies and targeting reduced greenhouse emissions.

This is placing considerable pressure on coal-fired power generation but is a boon for renewable energy businesses like Brookfield Renewable Energy Partners L.P. (TSX:BEP.UN)(NYSE:BEP). It is a global leader in providing renewable electricity generation with a portfolio of high quality assets in North America, South America, and Western Europe. It has also embarked on an aggressive expansion program with it set to deploy over US$4 billion for growth and acquisitions in coming years with a focus on boosting its presence in Western Europe. This is of particular importance because Western Europe’s electricity market is favourably disposed to renewable energy solutions.

3. An increasingly affluent, aging population

Longer life spans and lower birth rates in developed countries has created a demographic shift to aging populations that bodes exceptionally well for healthcare and pharmaceutical companies alike.

This secular tailwind will be of considerable benefit for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

You see, Valeant is the owner of the manufacturer of eye care products Bausch and Lomb, giving it access to the lucrative eye care market. This segment is of particular importance for an aging demographic because it is estimated that three-quarters of all eye conditions are age-related.

Furthermore, Valeant has a diverse portfolio of medical devices and pharmaceuticals, the demand for which can only grow as a greater proportion of the population ages.

These secular trends will significantly benefit each of the companies discussed, helping to drive long term earnings growth while shielding them from cyclical economic forces. Over time, this should see them deliver considerable value for investors making them important growth oriented additions for any portfolio.

Fool contributor Matt Smith has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals. Rogers is a recommendation of Stock Advisor Canada and Pro Canada.

More on Investing

Canadian dollars in a magnifying glass
Dividend Stocks

Monthly Income: Top Dividend Stocks to Buy in December

These two top Canadian dividend stocks could add steady monthly income to your portfolio while offering room to grow.

Read more »

Oil industry worker works in oilfield
Energy Stocks

Should You Buy Suncor or Canadian Natural Resources Now?

Suncor and Canadian Natural Resources are up in recent months. Are more gains on the way for one of these…

Read more »

dividends grow over time
Dividend Stocks

1 Canadian Stock to Dominate Your Portfolio in 2026

Down almost 40% from all-time highs, goeasy is a Canadian stock that offers significant upside potential to shareholders.

Read more »

Piggy bank on a flying rocket
Investing

The Best Stocks to Invest $3,000 in a TFSA Right Now

These Canadian stocks have solid fundamentals and strong future growth potential, making them best stocks for a TFSA.

Read more »

Woman checking her computer and holding coffee cup
Investing

TFSA: 3 Canadian Stocks to Buy and Hold Forever

Explore the advantages of investing in a TFSA and discover three Canadian compounder stocks to enhance your portfolio.

Read more »

Safety helmets and gloves hang from a rack on a mining site.
Metals and Mining Stocks

2 Gold Stocks That Won Big in 2025 Look Set to Dominate Next Year, Too

Two high-flying mining stocks could deliver a more than 100% return again if the gold rush extends in 2026.

Read more »

a-developer-typing-lines-of-ai-code-while-viewing-multiple-computer-monitors
Energy Stocks

Buy 928 Shares of This Stock for $300 in Monthly Dividend Income

Enbridge (TSX:ENB) has a 5.8% dividend yield.

Read more »

woman checks off all the boxes
Energy Stocks

5 Reasons to Buy and Hold This Canadian Stock for Life

Altagas offers investors exposure to the stable and growing utilities business as well as the lucrative LNG business.

Read more »